U.S. Markets open in 59 hrs, 3 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 9.30 03:59 PM EDT | |
|---|---|---|
| Day High | 9.73 09:32 AM EDT |
|
| Range | 0.43 |
| Volume | 275,762 | |
|---|---|---|
| 30-Day Avg Vol | 364,000 |
|
| Difference | -24.24% |
| Market Cap | 799.02 M | |
|---|---|---|
| Mkt Cap Chg | -38.53 M |
| Shares Out | 85.64 M | |
|---|---|---|
| % Shrs Traded | 0.32% | |
| 1yr EPS Est | -1.134 |
| 52-Wk Low | 6.81 10/10/08 | |
|---|---|---|
| 52-Wk High | 13.40 9/19/08 |
|
| Range | 6.59 |
| Prev Close | 9.78 7/1/09 | |
|---|---|---|
| Today's Open | 9.67 | |
| Change | -1.12% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 5.38 M |
| Revenue (LFY) | 35.23 M | |
|---|---|---|
| Earnings (LFY) | -85.50 M | |
| Earnings (MRQ) | -27.27 M | |
| Next Earn Est | -0.29 | |
| Next Earnings | 07/24/2009 |
|
| EPS (TTM) | -1.19 | |
| 1yr EPS Growth | 3.90% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -8.00 | |
| PEG Ratio | — | |
| Return on Equity | -121.80 | |
| Beta | 1.09 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Seattle Genetics is working on monoclonal antibodies (MAbs) to treat a variety of cancers and autoimmune diseases. It is developing MAbs potent enough to fight cancer on their own, as well as those used ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.29 7/24/09 | — — |
—
—
|
| Last Quarter | -0.29 3/31/09 | -0.33 3/31/09 |
-0.04
Missed
|
| 2 Quarters Ago | -0.305 12/31/08 | -0.38 12/31/08 |
-0.075
Missed
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 9.14 M | 35.24 M |
| Gross Profit | 9.14 M | 31.82 M |
| Operating Income | -28.26 M | -91.79 M |
| Net Income | -27.27 M | -85.50 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts